AAAAAA
Results:
1-24
|
Results: 24
Authors:
Damia, G
Filiberti, L
Vikhanskaya, F
Carrassa, L
Taya, Y
D'incalci, M
Broggini, M
Citation: G. Damia et al., Cisplatinum and taxol induce different patterns of p53 phosphorylation, NEOPLASIA, 3(1), 2001, pp. 10-16
Authors:
Alvi, AJ
Rader, JS
Broggini, M
Latif, F
Maher, ER
Citation: Aj. Alvi et al., Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer, J CL PATH-M, 54(4), 2001, pp. 240-243
Authors:
Marchini, S
Broggini, M
Sessa, C
D'Incalci, M
Citation: S. Marchini et al., Development of distamycin-related DNA binding anticancer drugs, EXPERT OP I, 10(9), 2001, pp. 1703-1714
Authors:
Vikhanskaya, F
Bani, MR
Borsotti, P
Ghilardi, C
Ceruti, R
Ghisleni, G
Marabese, M
Giavazzi, R
Broggini, M
Taraboletti, G
Citation: F. Vikhanskaya et al., p73 overexpression increases VEGF and reduces thrombospondin-1 production:implications for tumor angiogenesis, ONCOGENE, 20(50), 2001, pp. 7293-7300
Authors:
Damia, G
Sanchez, Y
Erba, E
Broggini, M
Citation: G. Damia et al., DNA damage induces p53-dependent down-regulation of hCHK1, J BIOL CHEM, 276(14), 2001, pp. 10641-10645
Authors:
Marchini, S
Damia, G
Broggini, M
Pennella, C
Ripamonti, M
Marsiglio, A
Geroni, C
Citation: S. Marchini et al., 4-demethoxy-3 '-deamino-3 '-aziridinyl-4 '-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms, CANCER RES, 61(5), 2001, pp. 1991-1995
Authors:
Vikhanskaya, F
Marchini, S
Marabese, M
Galliera, E
Broggini, M
Citation: F. Vikhanskaya et al., p73 alpha overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line, CANCER RES, 61(3), 2001, pp. 935-938
Authors:
De Feudis, P
Vignati, S
Rossi, C
Mincioni, T
Giavazzi, R
D'Incalci, M
Broggini, M
Citation: P. De Feudis et al., Driving p53 response to bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis, NEOPLASIA, 2(3), 2000, pp. 202-207
Authors:
Salvatoni, A
Nosetti, L
Broggini, M
Nespoli, L
Citation: A. Salvatoni et al., Body composition and growth in asthmatic children treated with inhaled steroids, ANN ALLER A, 85(3), 2000, pp. 221-226
Authors:
Bertoni, F
Mullenbach, R
Broggini, M
Roggero, E
Cavalli, F
Cotter, FE
Zucca, E
Citation: F. Bertoni et al., Extranodal marginal zone B-cell lymphoma genotyping by Alu - Polymerase chain reaction, LEUK LYMPH, 38(5-6), 2000, pp. 605-610
Authors:
Razzini, G
Berrie, CP
Vignati, S
Broggini, M
Mascetta, G
Brancaccio, A
Falasca, M
Citation: G. Razzini et al., Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines, FASEB J, 14(9), 2000, pp. 1179-1187
Authors:
Bird, H
Broggini, M
Citation: H. Bird et M. Broggini, Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: A randomized, double blind, parallel group study, J RHEUMATOL, 27(12), 2000, pp. 2791-2797
Authors:
Vikhanskaya, F
D'Incalci, M
Broggini, M
Citation: F. Vikhanskaya et al., p73 competes with p53 and attenuates its response in a human ovarian cancer cell line, NUCL ACID R, 28(2), 2000, pp. 513-519
Authors:
Broggini, M
Buraggi, G
Brenna, A
Riva, L
Codegoni, AM
Torri, V
Lissoni, AA
Mangioni, C
D'Incalci, M
Citation: M. Broggini et al., Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients, ANTICANC R, 20(6C), 2000, pp. 4835-4840
Authors:
Minuzzo, M
Marchini, S
Broggini, M
Faircloth, G
D'Incalci, M
Mantovani, R
Citation: M. Minuzzo et al., Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743, P NAS US, 97(12), 2000, pp. 6780-6784
Authors:
Vikhanskaya, F
Broggini, M
Citation: F. Vikhanskaya et M. Broggini, p53 transfectants in ovarian cancer, METH MOL M, 39, 2000, pp. 187-191
Authors:
Marchini, S
Ciro', M
Broggini, M
Citation: S. Marchini et al., p53-independent caspase-mediated apoptosis in human leukaemic cells is induced by a DNA minor groove binder with antineoplastic activity, APOPTOSIS, 4(1), 1999, pp. 39-45
Authors:
Vikhanskaya, F
Colella, G
Valenti, M
Parodi, S
D'Incalci, M
Broggini, M
Citation: F. Vikhanskaya et al., Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage, CLIN CANC R, 5(4), 1999, pp. 937-941
Authors:
Bertoni, F
Codegoni, AM
Furlan, D
Tibiletti, MG
Capella, C
Broggini, M
Citation: F. Bertoni et al., CHKI frameshift mutations in genetically unstable colorectal and endometrial cancers, GENE CHROM, 26(2), 1999, pp. 176-180
Authors:
Codegoni, AM
Bertoni, F
Colella, G
Caspani, G
Grassi, L
D'Incalci, M
Broggini, M
Citation: Am. Codegoni et al., Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer, ONCOL RES, 11(7), 1999, pp. 297-301
Authors:
Codegoni, AM
Bertoni, F
Patregnani, C
Marinetti, E
D'Incalci, M
Broggini, M
Citation: Am. Codegoni et al., Allelic expression of p73 in human ovarian cancers, ANN ONCOL, 10(8), 1999, pp. 949-953
Authors:
Fullwood, P
Marchini, S
Rader, JS
Martinez, A
Macartney, D
Broggini, M
Morelli, C
Barbanti-Brodano, G
Maher, ER
Latif, F
Citation: P. Fullwood et al., Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer, CANCER RES, 59(18), 1999, pp. 4662-4667
Authors:
Marchini, S
Ciro, M
Gallinari, F
Geroni, C
Cozzi, P
D'Incalci, M
Broggini, M
Citation: S. Marchini et al., alpha-Bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity, BR J CANC, 80(7), 1999, pp. 991-997
Authors:
Colella, G
Marchini, S
D'Incalci, MD
Brown, R
Broggini, M
Citation: G. Colella et al., Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents, BR J CANC, 80(3-4), 1999, pp. 338-343
Risultati:
1-24
|